Evidence map›Paper›PMID 35237963›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Monitoring Cellular Proliferation, Migration, and Apoptosis Associated with Atherosclerosis Plaques In Vitro.

Kerry S Wadey, Alexandros Somos, Stephen J Cross, Lien M Reolizo, Jason L Johnson, Sarah J George

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kerry S WadeyDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Alexandros SomosDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Stephen J CrossDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Lien M ReolizoDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Jason L JohnsonDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Sarah J GeorgeDepartment of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. S.J.George@bristol.ac.uk.
University of Bristol · GB

Funding

British Heart Foundation FS/18/1/33234British Heart Foundation FS/18/74/33976British Heart Foundation PG/11/77/29110British Heart Foundation PG/14/49/30876British Heart Foundation PG/15/30/31390British Heart Foundation PG/15/43/31567British Heart Foundation PG/18/84/34124
6 · The paper itself

Abstract

Bromodeoxyuridine/5-bromo-2'-deoxyuridine (BrdU) is a nucleoside analog of thymidine and its incorporation into DNA during replication within S-phase of the cell cycle is used to quantify cell proliferation. Quantification of incorporated BrdU is considered the most direct measure of cell proliferation, and here we describe BrdU incorporation into cultured vascular smooth muscle cells (VSMCs) and endothelial cells in vitro. Incorporation of fluorescent-labeled ethynyldeoxyuridine/5-ethynyl-2'-deoxyuridine (EdU) is a novel alternative to BrdU assays and presents significant advantages. This method of detection of EdU based on a simple "click" chemical reaction, which covalently bonds EdU to a fluorescent dye is also outlined in this chapter with a protocol for quantitative analysis of EdU incorporation using a Fiji-based macro. We also describe how proliferation can be assessed by quantification of classical proliferative markers such as phopsho-Ser807/811 retinoblastoma (Rb), proliferating cell nuclear antigen (PCNA) and cyclin D1 by Western blotting. As these markers are involved in different aspects of the cell cycle regulation, examining their expression levels can not only reveal the relative population of proliferating cells but can also improve our understanding of the mechanism of action of a given treatment or intervention. The scratch wound assay is a simple and cost-effective technique to quantify cell migration. A protocol which involves creating a wound in a cell cultured monolayer and measuring the distance migrated by the cells after a predefined time period is also described. Gap creation can also be achieved via physical cell exclusion where cells are seeded in distinct reservoirs of a cell culture insert which reveal a gap upon removal. Cell migration may then be quantified by monitoring the rate of gap closure. The presence of cleaved caspase-3 is a marker of programmed cell death (apoptosis). To detect cleaved caspase-3 in vitro, immunocytochemistry and fluorescence can be performed as outlined in this chapter.

Indexed as

AtherosclerosisDeoxyuridineApoptosisBromodeoxyuridineCell ProliferationEndothelial CellsHumansBromodeoxyuridineDeoxyuridineApoptosisBrdUCleaved caspase-3DNA synthesisEdUEndothelial cellsImmunocytochemistryMigrationProliferationSmooth muscle cellsWestern blotting

Identifiers

PMID35237963
OpenAlexW4214830242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.